Neuropathology of multiple sclerosis - New concepts

Brain Research Bulletin

Volumn 61, Issue 3, 2003, Pages 321-326

  Kornek, Barbara ^a   Lassmann, Hans ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Axonal pathology; Immune mechanisms; Multiple sclerosis; Paraclinical markers

Indexed keywords

IMMUNOGLOBULIN; MARKER; MYELIN;

CELL DEGENERATION; CELLULAR IMMUNITY; CONFERENCE PAPER; DEMYELINATION; HUMAN; MACROPHAGE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DEPLETION;

EID: 0041589180     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(03)00095-9     Document Type: Conference Paper

References (76)

1. Aquino D.A., Capello E., Weinstein J., Sanders V., Lopez C., Tourtellotte W.W., Brosnan C.F., Raine C.S., Norton W.T. Multiple sclerosis: altered expression of 70 and 27 kDa heat shock proteins in lesions and myelin. J. Neuropathol. Exp. Neurol. 56:1997;664-672.
2. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., Friese M., Schroder R., Deckert M., Schmidt S., Ravid R., Rajewsky K. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192:2000;393-404.
3. Battistini L., Salvetti M., Ristor G., Falcone M., Raine C.S., Brosnan C.F. Gamma delta T cell receptor analysis supports a role for HSP 70 selection of lymphocytes in multiple sclerosis lesions. Mol. Med. 1:1995;554-562.
4. Bergeron M., Yu A.Y., Solway K.E., Semenza G.L., Sharp F.R. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischemia in rat brain. Eur. J. Neurosci. 11:1999;4159-4170.
5. Bertolotto A., Malucchi S., Capobianco M., Manzardo E., Guastamacchia G., Minlano E., Audano L., Mutani R. Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses. J. Interferon Cytokine Res. 19:1999;575-581.
6. Birnbaum G., Kotilinek L. Heat shock or stress proteins and their role as autoantigens in multiple sclerosis. Ann. NY Acad. Sci. 835:1997;157-167.
7. Bitsch A., Bruhn H., Vougioukas V., Stringaris A., Lassmann H., Frahm J., Bruck W. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. Am. J. Neuroradiol. 20:1999;1619-1627.
8. Bitsch A., da Costa C., Bunkowski S., Weber F., Rieckmann P., Bruck W. Identification of macrophage populations expressing tumor necrosis factor-alpha mRNA in acute multiple sclerosis. Acta Neuropathol. Berl. 95:1998;373-377.
9. Bitsch A., Kuhlmann T., Stadelmann C., Lassmann H., Lucchinetti C., Bruck W. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann. Neurol. 49:2001;793-796.
10. Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain. 123:2000;1174-1183.
11. Bogumil T., Rieckmann P., Kubuschok B., Felgenhauer K., Bruck W. Serum levels of macrophage-derived protein MRP-8/14 are elevated in active multiple sclerosis. Neurosci. Lett. 247:1998;195-197.
12. Brex P.A., Parker G.J., Leary S.M., Molyneax P.D., Berker G.J., Davie C.A., Thompson A.J., Miller D.H. Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentration. J. Neurol. Neurosurg. Psychiatry. 68:2000;627-632.
13. Brosnan C.F., Battistini L., Gao Y.L., Raine C.S., Aquino D.A. Heat shock proteins and multiple sclerosis: a review. J. Neuropathol. Exp. Neurol. 55:1996;389-402.
14. Bruck W., Bitsch A., Kolenda H., Bruck Y., Stiefel M., Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann. Neurol. 42:1997;783-793.
15. Bruck W., Porada P., Poser S., Rieckmann P., Hanefeld F., Kretzschmar H.A., Lassmann H. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 38:1995;788-796.
16. Cannella B., Raine C. The adhesion molecule and cytokine profile of MS lesions. Ann. Neurol. 37:1995;424-435.
17. Carrieri P.B., Provitera V., de Rosa T., Tartaglia G., Gorga F., Perrella O. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol. Immunotoxicol. 20:1998;373-382.
18. Celet B., Akman-Demir G., Serdaroglu P., Yentur S.P., Tasci B., van Noort J.M., Eraksoy M., Saruhan-Direskeneli G. Anti-alpha B-crystalline immunoreactivity in inflammatory nervous system diseases. J. Neurol. 247:2000;935-939.
19. A. Compston, Genetic susceptibility to multiple sclerosis, in: McAlpine's Multiple Sclerosis, 3rd ed., Churchill Livingstone, Edinburgh, 1998.
20. Compston D.A., Morgan B.P., Campbell A.K., Wilkins P., Cole G., Thomas N.D., Jasani B. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol. Appl. Neurobiol. 15:1989;307-316.
21. Davie C.A., Barker G.J., Webb S., Tofts P.S., Thompson A.J., Harding A.E., McDonald W.I., Miller D.H. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain. 118:1995;1583-1592.
22. De Stefano N., Matthews P.M., Fu L., Narayanan S., Stanley J.M., Francis G.S., Antel J.P., Arnold D.L. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain. 121:1998;1469-1477.
23. Fazekas F., Strasser-Fuchs S., Kollegger H., Berger T., Kristoferitsch W., Schmidt H., Enzinger C., Schiefermeier M., Schwarz C., Kornek B., Reindl M., Huber K., Grass R., Wimmer G., Vass K., Pfeiffer K.H., Hartung H.P., Schmidt R. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology. 57:2001;853-857.
24. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain. 120:1997;393-399.
25. Filippi M., Rovaris M. Magnetisation transfer imaging in multiple sclerosis. J. Neurovirol. 6:2000;S115-S120.
26. Forbes R.B., Lees A., Waugh N., Swingler R.J. Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis. Br. Med. J. 319:1999;1529-1533.
27. Forsythe J.A., Jiang B.H., Iyer N.V., Agami F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor-1. Mol. Cell Biol. 16:1996;4604-4613.
28. Griot C., Vandevelde M., Richard A., Peterhans E., Stocker R. Selective degeneration of oligodendrocytes mediated by reactive oxygen species. Free Radic. Res. Commun. 11:1990;181-193.
29. Haase C.G., Guggenmos J., Brehm U., Andersson M., Olsson T., Reindl M., Schneidewind J.M., Zettl U.K., Heidenreich F., Berger T., Wekerle H., Hohlfeld R., Linington C. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114:2001;220-225.
30. Itoyama Y., Webster H.D., Sternberger N.H., Richardson E.P., Walker D.L., Quarles R.H., Padgett B.L. Distribution of papovavirus, myelin-associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions. Ann. Neurol. 11:1982;396-407.
31. Jans H., Heltberg A., Raun N.E. Circulating immune complexes and complement in the course of multiple sclerosis. Acta Neurol. Scand. 66:1982;488-496.
32. Keinanen R., Vartiainen N., Koistinaho J. Molecular cloning and characterization of the rat inducible nitric oxide synthase (iNOS) gene. Gene. 234:1999;297-305.
33. Kinouchi H., Sharp F.R., Hill M.P., Koistinaho J., Hicks K., Kamii H., Chan P.H. Induction of heat shock hsp70 mRNA and HSP70 kDa protein in neurons in the 'penumbra' following focal cerebral ischemia in the rat. Brain Res. 619:1993;334-338.
34. Kornek B., Lassmann H. Axonal pathology in multiple sclerosis. A historical note. Brain Pathol. 9:1999;651-656.
35. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., Linington C., Schmidbauer M., Lassmann H. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157:2000;267-276.
36. Kraus J., Engelhardt B., Chatzimanolis N., Bauer R., Tofighi J., Kuehne B.S., Laske C., Stolz E., Frielinghaus P., Schaefer C., Blaes F., Traupe H., Kaps M., Oschmann P. Cell surface bound soluble adhesion molecules in CSF and blood in multiple sclerosis: correlation with MRI-measures of subclinical disease severity and activity. J. Neuroimmunol. 122:2002;175-185.
37. H. Lassmann, Pathology of multiple sclerosis, in: McAlpine's Multiple Sclerosis, 3rd ed., Churchill Livingstone, Edinburgh, 1998.
38. Lassmann H., Bruck W., Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 7:2001;115-121.
39. Lee P.J., Jiang B.H., Chin B.Y., Iyer N.V., Alam J., Semenza G.L., Choi A.M. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme-oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272:1997;5375-5381.
40. Li Y., Chopp M., Garcia J.H., Yoshida Y., Zhang Z.G., Levine S.R. Distribution of the 72-kDa heat-shock protein as a function of transient focal cerebral ischemia in rats. Stroke. 23:1992;1292-1298.
41. Li Y., Chopp M., Zhang Z.G., Zhang R.L., Garcia J.H. Neuronal survival is associated with 72-kDa heat shock protein expression after transient middle cerebral artery occlusion in the rat. J. Neurol. Sci. 120:1993;187-194.
42. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination [see comments]. Ann. Neurol. 47:2000;707-717.
43. Lucchinetti C.et al. Humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Neurology. 54:2000;A259.
44. Matthews P.M., De Stefano N., Narayanan S., Francis G.S., Wolinsky J.S., Antel J.P., Arnold D.L. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin. Neurol. 18:1998;327-336.
45. McCallum K., Esiri M.M., Tourtellotte W.W. T cell subsets in multiple sclerosis lesions. Brain. 110:1987;1297-1308.
46. McGeer P.L., Kawamata T., Walker D.G., Akiyama H., Tooyama I., McGeer E.G. Microglia in degenerative neurological disease. Glia. 7:1993;84-92.
47. Mead R.J., Singhrao S.K., Neal J.W., Lassmann H., Morgan B.P. The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J. Immunol. 168:2002;458-465.
48. Merrill J.E. Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J. Immunother. 12:1992;167-170.
49. Mews I., Bergmann M., Bunkowski S., Gullotta F., Bruck W. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult. Scler. 4:1998;55-62.
50. Mies G., Ishimaru S., Xie Y., Seo K., Hossmann K.A. Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat. J. Cereb. Blood Flow Metab. 11:1991;753-761.
51. Moll C., Mourre C., Lazdunski M., Ulrich J. Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res. 556:1991;311-316.
52. Navikas V., Link H. Cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
53. Pinter C., Beltrami S., Caputo D., Ferrante P., Clivio A. Presence of autoantibodies against complement regulatory proteins in relapsing-remitting multiple sclerosis. J. Neurovirol. 6:2000;S42-S46.
54. Prineas J.W., Kwon E.E., Cho E.S., Sharer L.R., Barnett M.H., Oleszak E.L., Hoffman B.S., Morgan B.P. Immunopathology of secondary progressive multiple sclerosis. Ann. Neurol. 50:2001;646-657.
55. Ratcliffe P., Rourke J., Maxwell P. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J. Exp. Biol. 201:1998;1153-1162.
56. Reindl M., Linington C., Brehm U., Egg R., Dilitz E., Deisenhammer F., Poewe W., Berger T. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain. 122:1999;2047-2056.
57. Rieckmann P., Altenhofen B., Riegel A., Kallmann B., Felgenhauer K. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis. Mult. Scler. 4:1998;178-182.
58. Sanders M.E., Koski C.L., Robbins D., Shin M.L., Frank M.M., Joiner K.A. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis. J. Immunol. 136:1986;4456-4459.
59. Sellebjerg F., Christiansen M., Garred P. MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis. Mult. Scler. 4:1998;127-131.
60. Semenza G.L. Perspectives on oxygen sensing. Cell. 98:1999;281-284.
61. Sharp F.R., Aigang L., Tang Y., Millhorn D.E. Multiple molecular penumbras after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20:2000;1011-1032.
62. Soriano M.A., Planas A.M., Rodriguez-Farre E., Ferrer I. Early 72-kDa heat shock protein induction in microglial cells following focal ischemia in the rat brain. Neurosci. Lett. 182:1994;205-207.
63. Steinman L. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 194:2001;F27-F30.
64. Storch M.K., Piddlesden S., Haltia M., Iivanainen M., Morgan P., Lassmann H. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43:1998;465-471.
65. Strunk T., Bubel S., Mascher B., Schlenke P., Kirchner H., Wandinger K.P. Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients. Ann. Neurol. 47:2000;269-273.
66. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis [see comments]. N. Engl. J. Med. 338:1998;278-285.
67. Trapp B.D., Ransohoff R., Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 12:1999;295-302.
68. van Oosten B.W., Barkhof F., Scholten P.E., von Blomberg B.M., Ader H.J., Polman C.H. Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosis. Arch. Neurol. 55:1998;793-798.
69. Waubant E., Goodkin D.E., Gee L., Bacchetti P., Sloan R., Stewart T., Andersson P.B., Stabler G., Miller K. Serum MMp-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology. 53:1999;1397-1401.
70. Weinshenker B.G. The natural history of multiple sclerosis: update 1998. Semin. Neurol. 18:1998;301-307.
71. Weinshenker B.G., O'Brien P.C., Petterson T.M., Noseworthy J.H., Lucchinetti C.F., Dodick D.W., Pineda A.A., Stevens L.N., Rodriguez M. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann. Neurol. 46:1999;878-886.
72. H. Wekerle, Immunology of multiple sclerosis, in: A. Compston (Ed.), McAlpine's Multiple Sclerosis, 3rd ed., Churchill Livingstone, Edinburg, 1998.
73. Wekerle H., Linington C., Lassmann H., Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci. 9:1986;271-277.
74. Werring D.J., Brassat D., Droogan A.G., Clark C.A., Symms M.R., Barker G.J., MacManus D.G., Thompson A.J., Miller D.H. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis. Brain. 123:2000;1667-1676.
75. Woodroofe M.N., Bellamy A.S., Feldmann N. Immunocytochemical characterization of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J. Neurol. Sci. 174:1986;135-152.
76. Youl B.D., Turano G., Miller D.H., Towell A.D., MacManus D.G., Moore S.G., Jones S.J., Barrett G., Kendall B.E., Moseley I.F.et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain. 114:1991;2437-2450.